In the initial phase, five 5G-enabled ambulances is covering the immediate neighbourhood of the hospital, while the second phase will see an additional five ambulances extending coverage to neighbouring districts, further enhancing emergency response capabilities across the region.
The launch event was feature Sri Sri Prakashnath Swamiji, Managing Director, BGS & SJB Group of Institutions; Smt Anita B Haddannavar, IPS, Deputy Commissioner of Police, Traffic West Division, Bengaluru City; Anurag Yadav, CEO, Gleneagles India; Biju Nair, CEO, Gleneagles Bengaluru Cluster; Ravjot Singh Arora, Co-founder and COO, Medulance; Pranav Bajaj, Co-founder and CEO, Medulance; and Namita Thapar, Executive Director of Emcure Pharmaceuticals and Investor, Medulance.
 |
 |
The 5G-enabled ambulances are equipped with high-speed connectivity from Reliance Jio, enabling real-time, two-way audio and video communication. They also feature cameras and smart devices for high-definition footage transmission, along with Advanced Life Support (ALS) systems for critical medical interventions. These ambulances facilitate real-time streaming of patient health data to distant doctors and transmission of vital signs to emergency room dashboards. Additionally, they incorporate ambulance location tracking for efficient dispatch and navigation, as well as remote monitoring capabilities allowing doctors to guide paramedics.
With faster response times due to real-time data relay and monitoring, the ambulances reduce response times to less than 4 minutes in corporate settings. Patients benefit from real-time clinical assessment and immediate medical intervention during transit, along with remote assistance from doctors, enabling treatment during the commute. Effective use of the 'Golden Hour' and 'Platinum 10 Minutes' for critical care significantly improves survival rates in emergencies like heart attacks and strokes. Moreover, these ambulances enhance healthcare access in rural and remote areas and facilitate seamless data sharing with hospitals to prepare for incoming patients. The higher bandwidth and ultra-low latency of the 5G network ensure efficient data transfer, while integration with corporate wellness programs helps reduce healthcare costs and improve employee health outcomes.
Pranav Bajaj, Co-founder and CEO, Medulance, commented on the partnership, "Today, we mark a significant milestone in revolutionising emergency medical response. Our 5G-enabled ambulances, in partnership with Gleneagles BGS Hospital, Kengeri, will set a new standard for patient care. With cutting-edge technology, we're bridging the gap between emergency and treatment, ensuring timely and informed care. This innovation is a testament to our commitment to saving lives and shaping the future of healthcare.”
Ravjot Singh Arora, Co-founder and COO, Medulance said,”The launch of 5G-enabled ambulances is a dream come true for us. We've always envisioned a future where technology meets healthcare to save lives. With this innovation, we're empowering paramedics, doctors, and patients to connect in real-time, making emergency response more efficient and effective. We're proud to be at the forefront of this revolution in healthcare."
Anurag Yadav, CEO, Gleneagles India, expressed enthusiasm, stating, "We are thrilled to introduce the first 5G-enabled ambulance service in South India. This initiative is a part of our larger strategy to revolutionise emergency medical services across all Gleneagles hospitals, ensuring that we provide the highest level of care to our patients."
Biju Nair, CEO, Gleneagles Bengaluru Cluster, emphasised the hospital's commitment to excellence in emergency care, saying, "Achieving excellence in emergency care is a cornerstone of our mission at Gleneagles Bengaluru. The introduction of 5G-enabled ambulances is significantly enhancing our ability to provide immediate, high-quality medical intervention, setting a new standard for emergency response in the region."
This pioneering step reaffirms Gleneagles BGS Hospital's commitment to integrating advanced technology in healthcare, ensuring better outcomes for patients and setting new benchmarks in emergency medical services.
The Gleneagles Hospitals Bengaluru Cluster, an eminent duo of healthcare institutions that stand as pillars of medical excellence and compassionate care in the heart of Bengaluru. As integral parts of Gleneagles Healthcare India, aligned with the global reach and expertise of IHH Healthcare, these hospitals are a testament to our commitment to providing exceptional patient care, driven by a dedication to medical excellence, innovation, and patient-centricity.
Medulance is an innovative and first-of-its-kind integrated emergency healthcare service provider in the country that offers fast and reliable first-point medical attention. With an aim to save lives, Medulance responds to medical emergencies promptly, if and when they arise, in a manner that is quick, professional, and at par with international standards. Using its efficient dispatch technology and 5G-enabled smart ambulances, Medulance has been able to bring down the average response time from 45 minutes to under 11 minutes in some areas of Delhi. The platform can assist with over 6,000 calls daily. It also manages medical equipment and other consumables required in the ambulances along with the manpower (drivers and paramedics). Medulance strategically stations its ambulances at different locations identified based on emergency data. This data is recorded on parameters like the performance of the ambulance (including response time, calls per ambulance, dispatch time, etc) and the patient details such as Covid/non-Covid and other emergency condition necessities. To streamline the process and increase efficiency, such data is captured and analyzed daily.
The company has secured $3 million in Series A funding, led by Alkemi Growth Capital in 2024. It has received recognition for its innovative efforts, including the prestigious ‘National Start-up Award’ in 2022 and ‘Most Innovative 5G Use Case Deployed of the Year’ at the India Mobile Congress 2023 affirming the company’s impact and leadership in the healthcare sector.
Advertisements